| 07/16/2026 12:38 PM | Translational Development Acquisition (1926599) Subject WOLVERINE ASSET MANAGEMENT LLC (1279891) Filed by | Form SCHEDULE 13G/A | |
| 07/08/2026 7:05 AM | Translational Development Acquisition (1926599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/29/2026 5:11 AM | Prologium Holding Inc. (2137754) Filed by Translational Development Acquisition (1926599) Subject | Form 425 | |
| 06/23/2026 9:25 AM | Translational Development Acquisition (1926599) Filer | Form DEFA14A | |
| 06/23/2026 9:18 AM | Translational Development Acquisition (1926599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/23/2026 9:21 AM | Translational Development Acquisition (1926599) Subject | Form 425 | |
| 06/23/2026 8:50 AM | Prologium Holding Inc. (2137754) Filed by Translational Development Acquisition (1926599) Subject | Form 425 | |
| 06/22/2026 5:04 AM | Prologium Holding Inc. (2137754) Filed by Translational Development Acquisition (1926599) Subject | Form 425 | |
| 06/18/2026 8:23 AM | Translational Development Acquisition (1926599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/15/2026 5:07 AM | Prologium Holding Inc. (2137754) Filed by Translational Development Acquisition (1926599) Subject | Form 425 | |
| 06/12/2026 3:06 PM | Translational Development Acquisition (1926599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for TDACU and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Translational Development Acquisition and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/10/2026 1:07 PM | Prologium Holding Inc. (2137754) Filed by Translational Development Acquisition (1926599) Subject | Form 425 | |
| 06/03/2026 9:13 AM | Prologium Holding Inc. (2137754) Filed by Translational Development Acquisition (1926599) Subject | Form 425 | |
| 06/02/2026 1:23 PM | Linden Capital L.P. (1349339) Filed by Translational Development Acquisition (1926599) Subject | Form SCHEDULE 13G | |
| 05/29/2026 3:05 PM | Hoffman Michael B (1290208) Reporting Translational Development Acquisition (1926599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 4:21 PM | Translational Development Acquisition (1926599) Filer | Form DEFA14A | |
| 05/27/2026 4:07 PM | Translational Development Acquisition (1926599) Filer | Form DEF 14A | |
| 05/27/2026 6:37 AM | Translational Development Acquisition (1926599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/27/2026 6:40 AM | Translational Development Acquisition (1926599) Subject | Form 425 | |
| 05/15/2026 5:00 AM | Translational Development Acquisition (1926599) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/13/2026 9:53 AM | GOLDMAN SACHS GROUP INC (886982) Filed by Translational Development Acquisition (1926599) Subject | Form SCHEDULE 13G | |
| 05/11/2026 1:08 PM | Translational Development Acquisition (1926599) Filer | Form 10-K/A | |
| 05/06/2026 12:27 PM | Translational Development Acquisition (1926599) Filer | Form 10-K/A | |
| 05/01/2026 4:28 PM | Translational Development Acquisition (1926599) Filer | Form PRE 14A | |
| 10/10/2025 12:46 PM | Translational Development Acquisition (1926599) Subject WOLVERINE ASSET MANAGEMENT LLC (1279891) Filed by | Form SCHEDULE 13G/A | |